Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brompheniramine
2. Brompheniramine Maleate (1:1)
3. Chlorphed
4. Dimetane
5. Dimetane Ten
6. Dimetane-ten
7. Dimetapp Allergy
8. Maleate, Brompheniramine
9. Oraminic 2
10. Oraminic-2
11. P Bromdylamine
12. P-bromdylamine
13. Para Bromdylamine
14. Para-bromdylamine
1. 980-71-2
2. Brompheniramine Hydrogen Maleate
3. Dimetane
4. Rolabromophen
5. Dimotane
6. Parabromdylamine Maleate
7. Veltane
8. Dimetane-ten
9. Brompheniramine (maleate)
10. Lodrane
11. Brompheniramine Maleate [usp]
12. (+/-)-brompheniramine Maleate
13. Dimetapp Allergy
14. Nsc-758652
15. Ixa7c9zn03
16. Mls000028423
17. Chebi:3184
18. (+/-)-brompheniramine Maleate Salt
19. Drauxin
20. Gammistin
21. Nagemid
22. Smr000058417
23. Spentane
24. Allent
25. Ebalin
26. 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate
27. Brompheniramine Maleate (usp)
28. Drixoral Syrup
29. Mfcd00057367
30. Dimetane Extentabs
31. Bromopheniramine Maleate
32. Sr-01000003057
33. Einecs 213-562-9
34. Unii-ixa7c9zn03
35. Brompheniraminemaleate
36. 2-[p-bromo-alpha-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate
37. Dimetane (tn)
38. Prestwick_913
39. 3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
40. Brompheniramine Fumarate
41. 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine;(z)-but-2-enedioic Acid
42. Opera_id_399
43. 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)
44. (y)-brompheniramine Maleate
45. (?)-brompheniramine Maleate
46. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (+-)-, (z)-2-butenedioate (1:1)
47. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (z)-butenedioate (1:1)
48. Schembl41913
49. Mls001148196
50. Spectrum1503985
51. Bioompheniramine Hydrogen Maleate
52. Chembl1200961
53. Dtxsid2052657
54. (a+/-)-brompheniramine Maleate
55. Bcpp000315
56. Hms1569o12
57. Hms1922o16
58. Hms2093o07
59. Hms2096o12
60. Hms2230i21
61. Hms2234d14
62. Hms3260j03
63. Hms3713o12
64. Hms3884j10
65. Pharmakon1600-01503985
66. Hy-b0480
67. Tox21_500201
68. Ccg-39068
69. Nsc758652
70. S2585
71. (+-)-2-p-bromo-alpha-2-(dimethylamino)ethylbenzylpyridine Maleate (1:1)
72. Akos015855858
73. Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1)
74. Ac-1311
75. Bcp9000453
76. Brompheniramine Maleate [mart.]
77. Brompheniramine Maleate [vandf]
78. Lp00201
79. Nsc 758652
80. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (+-)-, (z)-butenedioate (1:1)
81. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (2z)-2-butenedioate (1:1)
82. Brompheniramine Maleate [usp-rs]
83. Brompheniramine Maleate [who-dd]
84. Ncgc00093676-01
85. Ncgc00093676-02
86. Ncgc00093676-03
87. Ncgc00093676-04
88. Ncgc00093676-05
89. Ncgc00260886-01
90. As-14101
91. Smr000653459
92. Bcp0726000240
93. Brompheniramine Maleate [ep Impurity]
94. Brompheniramine Maleate [orange Book]
95. Eu-0100201
96. Sw197031-3
97. Brompheniramine Maleate [ep Monograph]
98. B 2390
99. Brompheniramine Maleate [usp Monograph]
100. D00663
101. ( Inverted Question Mark)-brompheniramine Maleate
102. Biphetap Component Brompheniramine Maleate
103. Dimetapp Component Brompheniramine Maleate
104. Bromanate Component Brompheniramine Maleate
105. Bromatapp Component Brompheniramine Maleate
106. Bromfed-dm Component Brompheniramine Maleate
107. Brompheniramine Maleate Component Of Biphetap
108. Brompheniramine Maleate Component Of Dimetapp
109. Dimetane-dc Component Brompheniramine Maleate
110. Dimetane-dx Component Brompheniramine Maleate
111. Sr-01000003057-2
112. Sr-01000003057-4
113. Sr-01000003057-5
114. Sr-01000003057-8
115. W-100095
116. Bromanate Dc Component Brompheniramine Maleate
117. Bromanate Dm Component Brompheniramine Maleate
118. Brompheniramine Maleate Component Of Bromanate
119. Brompheniramine Maleate Component Of Bromatapp
120. Brompheniramine Maleate Component Of Bromfed-dm
121. Myphetane Dc Component Brompheniramine Maleate
122. Q27105975
123. Brompheniramine Maleate Component Of Bromanate Dc
124. Brompheniramine Maleate Component Of Bromanate Dm
125. Brompheniramine Maleate Component Of Dimetane-dc
126. Brompheniramine Maleate Component Of Dimetane-dx
127. Brompheniramine Maleate Component Of Myphetane Dc
128. (+/-)-brompheniramine Maleate 100 Microg/ml In Methanol
129. 2- P-bromo-a-2-(dimethylamino)ethylbenzylpyridine Maleate
130. 2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine Maleate
131. Brompheniramine Maleate 1.0 Mg/ml In Methanol (as Free Base)
132. 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane Maleate
133. 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine Maleate
134. Gamma-(4-bromophenyl)-n,n-dimethyl-2-pyridinepropanamine Maleate
135. (+/-)-brompheniramine Maleate 100 Microg/ml In Acetonitrile:methanol
136. 3-(4-bromophenyl)-n,n-dimethyl-3-(2-pyridinyl)-1-propanamine Maleate
137. Brompheniramine Maleate, United States Pharmacopeia (usp) Reference Standard
138. (+/-)-2-p-bromo-.alpha.-2-(dimethylamino)ethylbenzylpyridine Maleate (1:1)
139. 3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine (2z)-but-2-enedioate
140. Brompheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
141. 2-pyridinepropanamine, .gamma.-(4-bromophenyl)-n,n-dimethyl-, (+/-)-, (z)-butenedioate (1:1)
142. 2664-17-7
143. Brompheniramine Maleate Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 435.3 g/mol |
---|---|
Molecular Formula | C20H23BrN2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 434.08412 g/mol |
Monoisotopic Mass | 434.08412 g/mol |
Topological Polar Surface Area | 90.7 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Brompheniramine maleate |
Active Ingredient | Brompheniramine maleate |
Dosage Form | Tablet |
Route | oral |
Strength | 4mg |
Market Status | Prescription |
Company | Phoenix Labs Ny; Nylos |
2 of 4 | |
---|---|
Drug Name | Veltane |
Active Ingredient | Brompheniramine maleate |
Dosage Form | Tablet |
Route | oral |
Strength | 4mg |
Market Status | Prescription |
Company | Lannett |
3 of 4 | |
---|---|
Drug Name | Brompheniramine maleate |
Active Ingredient | Brompheniramine maleate |
Dosage Form | Tablet |
Route | oral |
Strength | 4mg |
Market Status | Prescription |
Company | Phoenix Labs Ny; Nylos |
4 of 4 | |
---|---|
Drug Name | Veltane |
Active Ingredient | Brompheniramine maleate |
Dosage Form | Tablet |
Route | oral |
Strength | 4mg |
Market Status | Prescription |
Company | Lannett |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Brompheniramine Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brompheniramine Maleate, including repackagers and relabelers. The FDA regulates Brompheniramine Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brompheniramine Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Brompheniramine Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Brompheniramine Maleate supplier is an individual or a company that provides Brompheniramine Maleate active pharmaceutical ingredient (API) or Brompheniramine Maleate finished formulations upon request. The Brompheniramine Maleate suppliers may include Brompheniramine Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Brompheniramine Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Brompheniramine Maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Brompheniramine Maleate active pharmaceutical ingredient (API) in detail. Different forms of Brompheniramine Maleate DMFs exist exist since differing nations have different regulations, such as Brompheniramine Maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Brompheniramine Maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Brompheniramine Maleate USDMF includes data on Brompheniramine Maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Brompheniramine Maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Brompheniramine Maleate suppliers with USDMF on PharmaCompass.
A Brompheniramine Maleate CEP of the European Pharmacopoeia monograph is often referred to as a Brompheniramine Maleate Certificate of Suitability (COS). The purpose of a Brompheniramine Maleate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Brompheniramine Maleate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Brompheniramine Maleate to their clients by showing that a Brompheniramine Maleate CEP has been issued for it. The manufacturer submits a Brompheniramine Maleate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Brompheniramine Maleate CEP holder for the record. Additionally, the data presented in the Brompheniramine Maleate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Brompheniramine Maleate DMF.
A Brompheniramine Maleate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Brompheniramine Maleate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Brompheniramine Maleate suppliers with CEP (COS) on PharmaCompass.
A Brompheniramine Maleate written confirmation (Brompheniramine Maleate WC) is an official document issued by a regulatory agency to a Brompheniramine Maleate manufacturer, verifying that the manufacturing facility of a Brompheniramine Maleate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Brompheniramine Maleate APIs or Brompheniramine Maleate finished pharmaceutical products to another nation, regulatory agencies frequently require a Brompheniramine Maleate WC (written confirmation) as part of the regulatory process.
click here to find a list of Brompheniramine Maleate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brompheniramine Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Brompheniramine Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Brompheniramine Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Brompheniramine Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brompheniramine Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Brompheniramine Maleate suppliers with NDC on PharmaCompass.
Brompheniramine Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brompheniramine Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brompheniramine Maleate GMP manufacturer or Brompheniramine Maleate GMP API supplier for your needs.
A Brompheniramine Maleate CoA (Certificate of Analysis) is a formal document that attests to Brompheniramine Maleate's compliance with Brompheniramine Maleate specifications and serves as a tool for batch-level quality control.
Brompheniramine Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Brompheniramine Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brompheniramine Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Brompheniramine Maleate EP), Brompheniramine Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brompheniramine Maleate USP).
LOOKING FOR A SUPPLIER?